{"abstract":"The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register on April 12, 2016 (81 FR 21559). The document announced an opportunity for a hearing on FDA's Center for Veterinary Medicine's proposal to withdraw approval of all new animal drug applications providing for use of carbadox in medicated swine feed and contained an incorrect telephone number for the individual to be contacted for further information. The address for Phibro Animal Health Corp. was also incorrect. This document corrects those errors.","action":"Notice of opportunity for hearing; correction.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2016/04/21/2016-09265.html","cfr_references":[],"citation":"81 FR 23499","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":null,"disposition_notes":null,"docket_ids":["Docket No. FDA-2016-N-0832"],"dockets":[],"document_number":"2016-09265","effective_on":null,"end_page":23499,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2016/04/21/2016-09265.xml","html_url":"https://www.federalregister.gov/documents/2016/04/21/2016-09265/phibro-animal-health-corp-carbadox-in-medicated-swine-feed-opportunity-for-hearing-correction","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2016-09265?publication_date=2016-04-21","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2016-04-21/2016-09265/mods.xml","not_received_for_publication":null,"page_length":1,"page_views":{"count":177,"last_updated":"2026-08-24 14:15:12 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2016-04-21/pdf/2016-09265.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2016-09265.pdf?1461156388","publication_date":"2016-04-21","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2016/04/21/2016-09265.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[{"title":"Exhibit 7 Expert Opinion of Stephen Scypinski, Ph.D. re: Request for Hearing from Phibro Animal Health Corporation Redacted CV","document_id":"FDA-2016-N-0832-0043"},{"title":"Exhibit 2 Expert Opinion of David H. Bechtel, Ph.D., D.A.B.T. re: Request for Hearing from Phibro Animal Health Corporation Redacted CV","document_id":"FDA-2016-N-0832-0040"},{"title":"Exhibit 20 Corey Grass, C. F. Grass Consulting, Impact & Cost if Mecadox Was Not Available (June 2016) re: Request for Hearing from Phibro Animal Health Corporation","document_id":"FDA-2016-N-0832-0038"},{"title":"Exhibit 15 A.C.J. Gresham, et al Treatment of Swine Dysentery Problems of Antibiotic Resistance and Concurrent Salmonellosis, 143 Vet. Rec. 619 (1998) re: Request for Hearing from Phibro Animal Health Corporation","document_id":"FDA-2016-N-0832-0037"},{"title":"Exhibit 14 M. Karlsson, et al Decreased Susceptibility to\nTiamulin in German Isolates of Brachyspira hyodysenteriae (Paper 43), Proc. 17th Int. Pig Vet. Soc. Cong., Ames, Iowa (2002) re: Request for Hearing from Phibro Animal Health Corporation","document_id":"FDA-2016-N-0832-0036"},{"title":"Exhibit 12 R. Korty, et al A Cost Effective Alternative to Finishing Depopulation for Swine Dysentery, Am. Ass. Swine Vet. re: Request for Hearing from Phibro Animal Health Corporation","document_id":"FDA-2016-N-0832-0035"},{"title":"Exhibit 10 Declaration of Kevin Bynum re: Request for Hearing from Phibro Animal Health Corporation","document_id":"FDA-2016-N-0832-0033"},{"title":"Exhibit 9 Declaration of Paul Duquette re: Request for Hearing from Phibro Animal Health Corporation","document_id":"FDA-2016-N-0832-0032"},{"title":"Exhibit 6 FDA Location Directory (July 1990)  re: Request for Hearing from Phibro Animal Health Corporation","document_id":"FDA-2016-N-0832-0031"},{"title":"Exhibit 5 Proceedings of the EuroResidue Conference, Noorwijkerhout re: Request for Hearing from Phibro Animal Health Corporation","document_id":"FDA-2016-N-0832-0030"}],"comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2016-N-0832","supporting_documents_count":38,"docket_id":"FDA-2016-N-0832","regulation_id_number":null,"title":"Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Opportunity for Hearing","checked_regulationsdotgov_at":"2016-05-11T06:00:17Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":23499,"subtype":null,"title":"Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Opportunity for Hearing; Correction","toc_doc":"Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Hearing; Correction","toc_subject":"Meetings:","topics":[],"type":"Notice","volume":81}